Clinical Trial Update: Observational Study of the Predictability of Levemir® in Terms of Metabolic Control, Change of Body Weight and Hypos

View source ↗

Summary

This completed observational study evaluated the predictability of Levemir (insulin detemir) in terms of metabolic control, changes in body weight, and hypoglyc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus
• Type 2 Diabetes Mellitus

Drugs mentioned

• Levemir (insulin detemir)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 1 | Status: COMPLETED